Integer Holdings Corporation
Medical device CDMO for cardiac devices
Account Manager
Approximately 50% travel is required, including occasional international travel.
About the job
- A Bachelor's Degree in Business, Marketing, or a related discipline is required.
- At least 5 years of experience in the medical device industry or related business-to-business sales is required.
- A proven successful track record in sales and territory management, including a strong prospecting component, is required.
- Proven experience selling components, sub-assemblies, or finished goods in a technical solutions-selling environment is required.
- A deep understanding of the medical device and/or contract manufacturing industry is required.
- Strength in sales call planning and execution and sales opportunity development is required.
- The ability to effectively call on mid-level management of major original equipment manufacturer medical manufacturers across Operations, Engineering, and Marketing is required.
- The ability to analyze, understand, and effectively communicate technical material is required.
- The ability to assess the financial impact of deals and opportunities is required.
- The ability to work collaboratively with and influence peers and management is required.
- The ability to address potential resolutions with customers and internal stakeholders and partner to move work forward is required.
- The ability to translate strategy into tactical implementation and motivate others to execute on the strategy is required.
- Strong interpersonal, presentation, and organizational skills are required.
- The ability to manage multiple significant activities and respond to changing priorities with minimal disruption is required.
- A disciplined, process-focused approach to managing personal workload and the ability to work without day-to-day supervision are required.
- A results-oriented work ethic and high tolerance for ambiguity are required.
- The ability to drive problem resolution in challenging situations is required.
- Proficiency in Outlook, Excel, Word, PowerPoint, and web-based applications is required.
- International travel requires appropriate travel documentation.
- Drive revenue and the future growth pipeline of assigned accounts by identifying and acquiring new opportunities while growing and preserving business within existing accounts.
- Implement a value-based selling process to increase commercial success while maximizing price and profitability.
- Develop and implement account and territory plans aligned with broader account and product category strategies.
- Collaborate with other Account Managers to ensure cohesive customer approaches and coverage.
- Meet or exceed sales goals for the defined territory by growing revenue, identifying and prioritizing opportunities, securing resources, executing sales strategies, and applying pull-through tactics.
- Identify, engage, and maintain relationships with key influencers and decision-makers, primarily Customer Directors and Managers.
- Stay informed about new products, services, customer business opportunities, account changes, current conditions, future prospects, active measurements, and the competitive landscape.
- Complete sales training, shop-floor experience, local training, and self-study to maintain relevant product and industry knowledge.
- Work with the Customer Success Team to define and track customer key performance indicators and help ensure service levels for assigned accounts are met.
- Work with the Applications Engineering Team to support commercial opportunities and resolve customer design, technical, or engineering challenges in a timely manner.
- Provide input to and follow critical commercial processes, metrics, key performance indicators, and business review cadence within the commercial team.
- Perform account business reviews with Integer's leadership team.
- Continually develop knowledge of company strategy and capabilities, including customer and industry trends.
- Maintain expenses within budget.
- Generate required reports.
- Perform other assigned duties.
- Completion of formal sales training program(s) is a plus.
About the company
Integer Holdings Corporation is a large medical device contract development and manufacturing organization (CDMO) that supports medical device makers in cardiac rhythm management, neuromodulation, and cardiovascular markets. It provides end-to-end services from design support to manufacturing, delivering components and finished subsystems such as implants, housings, electrodes, and batteries through its Greatbatch Medical, Lake Region Medical, and Electrochem brands. The company differentiates itself by its scale, breadth of capabilities across multiple medical specialties, established brand portfolio, and global manufacturing footprint that enable reliable, integrated supply. Its goal is to improve patients’ lives worldwide by helping customers bring safe and effective medical technologies to market.
Company Size
1,001-5,000
Company Stage
IPO
Headquarters
Wilmington, Delaware
Founded
1940
Get referred to Integer Holdings Corporation
See people who can refer or advise you
Simplify's Take
What believers are saying
- KKR will pay $127 cash per share, a 51.8% premium.
- Q2 2026 adjusted EPS hit $1.60, beating estimates by 15.9%.
- KKR plans capacity, technology, innovation, and employee ownership investments after closing.
What critics are saying
- New Ross shut for two unpaid weeks July 27-August 10, signaling demand volatility.
- Q2 2026 sales fell 2.6% to $464.1 million, with organic sales down 1.5%.
- Post-deal, Integer delists from NYSE and disappears if approvals or financing break.
What makes Integer Holdings Corporation unique
- KKR’s August 3, 2026 bid validates Integer’s critical medtech CDMO platform.
- Integer supplies components for cardiovascular, neuromodulation, and orthopedic devices across major manufacturers.
- The New Ross facility remains strategically important, with recent capacity and technology investments.
Help us improve and share your feedback! Did you find this helpful?
Benefits
Health Insurance
Dental Insurance
Vision Insurance
Life Insurance
Disability Insurance
Adoption Assistance
Parental Leave
401(k) Company Match
401(k) Retirement Plan
Paid Vacation
Paid Holidays
Company News
Boussard & Gavaudan Gestion Sas bought a new position in Integer Holdings Corporation (NYSE:ITGR – Free Report) during the 2nd quarter, according to its most recent filing with the Securities & Exchange Commission. The firm bought 28,153 shares of the medical equipment provider’s stock, valued at approximately $2,597,000. Other institutional investors and hedge funds also […]
Healthcare stocks have returned 26.1% over the past six months, outperforming the S&P 500 by 13.1 percentage points. However, investors must remain cautious due to heavy regulation affecting earnings potential. Integer Holdings faces concerns with 6.1% annual revenue growth over two years, lagging healthcare peers. Its modest revenue base of $1.84 billion provides less fixed cost leverage than larger competitors. The company trades at $125.07 per share, or 18.6 times forward price-to-earnings. Evolent Health shows weak platform performance and declining returns on capital. Its high net-debt-to-EBITDA ratio of 7 times could force unfavourable capital raises if market conditions worsen. Shares trade at $4.15, representing 12.4 times forward price-to-earnings. Tenet Healthcare, operating hospitals and surgical centres across nine US states, emerges as the recommended healthcare investment.
Integer Holdings agreed to be acquired by private equity firm KKR in an all-cash deal valued at approximately $5.7 billion. The transaction values the medical technology company at $127 per share. Shares jumped 2.7% in afternoon trading, continuing a rally from the previous session when the stock surged over 20% following the announcement. The acquisition news overshadowed strong second-quarter results, where Integer posted an adjusted profit of $1.60 per share on $464.1 million in revenue, surpassing analyst estimates. Following the buyout announcement, Integer withdrew its previously issued financial guidance and cancelled its upcoming earnings conference call. Shares traded at $124.50, marking a new 52-week high.
KKR has agreed to acquire Integer Holdings Corporation, a medical device contract development and manufacturing organisation, in an all-cash transaction valued at approximately $5.7 billion. Integer stockholders will receive $127 per share, representing a 51.8% premium to the company's closing share price on 29 April 2026. The acquisition follows a comprehensive strategic review announced by Integer in April 2026. The Integer Board unanimously approved the agreement and recommends stockholder approval. KKR plans to invest in Integer's capacity, technology, innovation, and talent. The firm also intends to establish a broad-based employee ownership programme following the transaction's close, consistent with its approach across portfolio companies. The transaction is expected to close by year-end, subject to stockholder approval and regulatory clearances. Upon completion, Integer will become privately held and delist from the New York Stock Exchange.
Integer Holdings Corp. reported second-quarter net income of $23.6 million, or 69 cents per share. Adjusted earnings came to $1.60 per share, exceeding Wall Street expectations of $1.38 per share. The Plano, Texas-based medical device outsource manufacturer posted revenue of $464.1 million for the period, also beating analyst forecasts of $452.5 million. The results surpassed predictions from five analysts surveyed by Zacks Investment Research on both earnings and revenue metrics.